 | • レポートコード：MRC2012A8006 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、レブラミドの世界市場を広く調査・分析し、今後の市場展望をまとめております。レブラミドの種類別市場規模（10mg、25mg、その他）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Celgene、 ・地域別グローバル市場分析 2015年-2020年 ・レブラミドの北米市場（アメリカ、カナダ、メキシコ） ・レブラミドのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・レブラミドのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・レブラミドの南米市場（ブラジル、アルゼンチン） ・レブラミドの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：10mg、25mg、その他 ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Revlimid market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Revlimid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Revlimid market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Revlimid market has been segmented into
10mg
25mg
Other
By Application, Revlimid has been segmented into:
Hospital
Drugs Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Revlimid market presented in the report. This section sheds light on the sales growth of different regional and country-level Revlimid markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Revlimid market.
The report offers in-depth assessment of the growth and other aspects of the Revlimid market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Revlimid Market Share Analysis
Revlimid competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Revlimid sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Revlimid sales, revenue and market share for each player covered in this report.
The major players covered in Revlimid are:
Celgene
Among other players domestic and global, Revlimid market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Revlimid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Revlimid, with price, sales, revenue and global market share of Revlimid in 2018 and 2019.
Chapter 3, the Revlimid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Revlimid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Revlimid market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Revlimid sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Revlimid Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Revlimid Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 10mg
1.2.3 25mg
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Revlimid Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Overview of Global Revlimid Market
1.4.1 Global Revlimid Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Celgene Details
2.1.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Celgene SWOT Analysis
2.1.4 Celgene Product and Services
2.1.5 Celgene Revlimid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Revlimid Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Revlimid Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Revlimid Manufacturer Market Share in 2019
3.3.2 Top 6 Revlimid Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Revlimid Sales, Revenue and Market Share by Regions
4.1.1 Global Revlimid Sales and Market Share by Regions (2015-2020)
4.1.2 Global Revlimid Revenue and Market Share by Regions (2015-2020)
4.2 North America Revlimid Sales and Growth Rate (2015-2020)
4.3 Europe Revlimid Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Revlimid Sales and Growth Rate (2015-2020)
4.5 South America Revlimid Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Revlimid Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Revlimid Sales, Revenue and Market Share by Country
5.1.1 North America Revlimid Sales and Market Share by Country (2015-2020)
5.1.2 North America Revlimid Revenue and Market Share by Country (2015-2020)
5.2 United States Revlimid Sales and Growth Rate (2015-2020)
5.3 Canada Revlimid Sales and Growth Rate (2015-2020)
5.4 Mexico Revlimid Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Revlimid Sales, Revenue and Market Share by Country
6.1.1 Europe Revlimid Sales and Market Share by Country (2015-2020)
6.1.2 Europe Revlimid Revenue and Market Share by Country (2015-2020)
6.2 Germany Revlimid Sales and Growth Rate (2015-2020)
6.3 UK Revlimid Sales and Growth Rate (2015-2020)
6.4 France Revlimid Sales and Growth Rate (2015-2020)
6.5 Russia Revlimid Sales and Growth Rate (2015-2020)
6.6 Italy Revlimid Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Revlimid Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Revlimid Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Revlimid Revenue and Market Share by Regions (2015-2020)
7.2 China Revlimid Sales and Growth Rate (2015-2020)
7.3 Japan Revlimid Sales and Growth Rate (2015-2020)
7.4 Korea Revlimid Sales and Growth Rate (2015-2020)
7.5 India Revlimid Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Revlimid Sales and Growth Rate (2015-2020)
7.7 Australia Revlimid Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Revlimid Sales, Revenue and Market Share by Country
8.1.1 South America Revlimid Sales and Market Share by Country (2015-2020)
8.1.2 South America Revlimid Revenue and Market Share by Country (2015-2020)
8.2 Brazil Revlimid Sales and Growth Rate (2015-2020)
8.3 Argentina Revlimid Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Revlimid Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Revlimid Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Revlimid Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Revlimid Sales and Growth Rate (2015-2020)
9.3 Turkey Revlimid Sales and Growth Rate (2015-2020)
9.4 Egypt Revlimid Sales and Growth Rate (2015-2020)
9.5 South Africa Revlimid Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Revlimid Sales and Market Share by Type (2015-2020)
10.2 Global Revlimid Revenue and Market Share by Type (2015-2020)
10.3 Global Revlimid Price by Type (2015-2020)
11 Global Revlimid Market Segment by Application
11.1 Global Revlimid Sales Market Share by Application (2015-2020)
11.2 Global Revlimid Revenue Market Share by Application (2015-2020)
11.3 Global Revlimid Price by Application (2015-2020)
12 Market Forecast
12.1 Global Revlimid Sales, Revenue and Growth Rate (2021-2025)
12.2 Revlimid Market Forecast by Regions (2021-2025)
12.2.1 North America Revlimid Market Forecast (2021-2025)
12.2.2 Europe Revlimid Market Forecast (2021-2025)
12.2.3 Asia-Pacific Revlimid Market Forecast (2021-2025)
12.2.4 South America Revlimid Market Forecast (2021-2025)
12.2.5 Middle East & Africa Revlimid Market Forecast (2021-2025)
12.3 Revlimid Market Forecast by Type (2021-2025)
12.3.1 Global Revlimid Sales Forecast by Type (2021-2025)
12.3.2 Global Revlimid Market Share Forecast by Type (2021-2025)
12.4 Revlimid Market Forecast by Application (2021-2025)
12.4.1 Global Revlimid Sales Forecast by Application (2021-2025)
12.4.2 Global Revlimid Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Revlimid Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Revlimid by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Revlimid Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Celgene Basic Information, Manufacturing Base and Competitors
Table 8. Celgene Revlimid Major Business
Table 9. Celgene Revlimid Total Revenue (USD Million) (2017-2018)
Table 10. Celgene SWOT Analysis
Table 11. Celgene Revlimid Product and Services
Table 12. Celgene Revlimid Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Revlimid Sales by Manufacturer (2018-2019) (MT)
Table 14. Global Revlimid Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Revlimid Sales by Regions (2015-2020) (MT)
Table 16. Global Revlimid Sales Market Share by Regions (2015-2020)
Table 17. Global Revlimid Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Revlimid Sales by Countries (2015-2020) (MT)
Table 19. North America Revlimid Sales Market Share by Countries (2015-2020)
Table 20. North America Revlimid Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Revlimid Revenue Market Share by Countries (2015-2020)
Table 22. Europe Revlimid Sales by Countries (2015-2020) (MT)
Table 23. Europe Revlimid Sales Market Share by Countries (2015-2020)
Table 24. Europe Revlimid Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Revlimid Sales by Regions (2015-2020) (MT)
Table 26. Asia-Pacific Revlimid Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Revlimid Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Revlimid Sales by Countries (2015-2020) (MT)
Table 29. South America Revlimid Sales Market Share by Countries (2015-2020)
Table 30. South America Revlimid Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Revlimid Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Revlimid Sales by Countries (2015-2020) (MT)
Table 33. Middle East & Africa Revlimid Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Revlimid Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Revlimid Revenue Market Share by Countries (2015-2020)
Table 36. Global Revlimid Sales by Type (2015-2020) (MT)
Table 37. Global Revlimid Sales Share by Type (2015-2020)
Table 38. Global Revlimid Revenue by Type (2015-2020) (USD Million)
Table 39. Global Revlimid Revenue Share by Type (2015-2020)
Table 40. Global Revlimid Sales by Application (2015-2020) (MT)
Table 41. Global Revlimid Sales Share by Application (2015-2020)
Table 42. Global Revlimid Sales Forecast by Regions (2021-2025) (MT)
Table 43. Global Revlimid Market Share Forecast by Regions (2021-2025)
Table 44. Global Revlimid Sales Forecast by Type (2021-2025) (MT)
Table 45. Global Revlimid Market Share Forecast by Type (2021-2025)
Table 46. Global Revlimid Sales Forecast by Application (2021-2025)
Table 47. Global Revlimid Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Revlimid Picture
Figure 2. Global Sales Market Share of Revlimid by Type in 2019
Figure 3. 10mg Picture
Figure 4. 25mg Picture
Figure 5. Other Picture
Figure 6. Revlimid Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Drugs Store Picture
Figure 9. Other Picture
Figure 10. Global Revlimid Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Revlimid Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Revlimid Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Revlimid Sales Market Share by Manufacturer in 2019
Figure 31. Global Revlimid Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Revlimid Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Revlimid Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Revlimid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Revlimid Revenue Market Share by Regions (2015-2020)
Figure 38. Global Revlimid Revenue Market Share by Regions in 2018
Figure 39. North America Revlimid Sales and Growth Rate (2015-2020)
Figure 40. Europe Revlimid Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Revlimid Sales and Growth Rate (2015-2020)
Figure 42. South America Revlimid Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Revlimid Sales and Growth Rate (2015-2020)
Figure 44. North America Revlimid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Revlimid Sales Market Share by Countries (2015-2020)
Figure 46. North America Revlimid Sales Market Share by Countries in 2018
Figure 47. North America Revlimid Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Revlimid Revenue Market Share by Countries in 2018
Figure 49. United States Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Revlimid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Revlimid Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Revlimid Revenue Market Share by Countries in 2019
Figure 55. Germany Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Revlimid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Revlimid Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Revlimid Revenue Market Share by Regions 2019
Figure 63. China Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Revlimid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Revlimid Sales Market Share by Countries in 2019
Figure 70. South America Revlimid Revenue Market Share by Countries in 2019
Figure 71. Brazil Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Revlimid Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Revlimid Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Revlimid Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Revlimid Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Revlimid Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Revlimid Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Revlimid Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Revlimid Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Revlimid Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Revlimid Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Revlimid Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Revlimid Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…- 院内肺炎治療薬の世界市場（～2026年） Hospital-acquired pneumonia (HAP) or nosocomial pneumonia refers to any pneumonia contracted by a patient in a hospital at least 48–72 hours after being admitted. It is thus distinguished from community-acquired pneumonia. It is usually caused by a bacterial infection, rather than a virus. Market An…
- 院内肺炎（HAP）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Hospital-acquired Pneumonia (HAP) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hospi…
- 病院用注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…
- 院内肺炎（HAP）治療薬の世界市場（～2026年） HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects …